case_images: PMC3814281_01
case_images: Tumour biopsy showing poorly differentiated cells with scarce cytoplasm and vesicular nuclei with inconspicuous nucleoli. High mitotic index and apoptotic figures were present. Immunohistochemical reactions were positive for cytokeratin 8 and 20 and neuroendocrine markers (chromogranin, synaptophysin and CD56/NCAM); TTF-1 was not expressed (H&E stain, 40x).
case_images: rado-47-04-366f1.jpg
case_images: PMC3814281_01_rado-47-04-366f1.jpg
case_images: f1-rado-47-04-366
case_images: A diagnosis of MCC was established (Figure 1).
case_images: Before first electrochemotherapy: voluminous bluish lesion of the chin.
case_images: rado-47-04-366f2.jpg
case_images: PMC3814281_01_rado-47-04-366f2.jpg
case_images: f2-rado-47-04-366
case_images: A biopsy of the mass confirmed recurrent MCC (Figure 2).
case_images: Reduction of 80% of the volume to the initial lesion after 2 treatments.
case_images: rado-47-04-366f3.jpg
case_images: PMC3814281_01_rado-47-04-366f3.jpg
case_images: f3-rado-47-04-366
case_images: The next ECT treatment resulted in 80% volume reduction compared to the original lesion (Figure 3).
case_images: Follow up after four electrochemotherapy applications and 16 months.
case_images: rado-47-04-366f4.jpg
case_images: PMC3814281_01_rado-47-04-366f4.jpg
case_images: f4-rado-47-04-366